- Home
- CGBD vs KOD Comparison
CGBD vs KOD Comparison
Compare CGBD & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGBD | KOD |
|---|---|---|
| Founded | 2012 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 906.2M | 1.5B |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CGBD | KOD |
|---|---|---|
| Price | $12.26 | $27.13 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $13.70 | ★ $22.67 |
| AVG Volume (30 Days) | 529.5K | ★ 1.1M |
| Earning Date | 02-24-2026 | 11-13-2025 |
| Dividend Yield | ★ 13.03% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $245,008,000.00 | N/A |
| Revenue This Year | $13.53 | N/A |
| Revenue Next Year | $4.24 | N/A |
| P/E Ratio | $11.13 | ★ N/A |
| Revenue Growth | ★ 2.55 | N/A |
| 52 Week Low | $11.55 | $1.92 |
| 52 Week High | $18.64 | $31.18 |
Technical Indicators
Market Signals| Indicator | CGBD | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 39.91 | 55.29 |
| Support Level | $12.25 | $23.92 |
| Resistance Level | $12.94 | $31.18 |
| Average True Range (ATR) | 0.23 | 2.41 |
| MACD | -0.04 | -0.47 |
| Stochastic Oscillator | 1.43 | 42.10 |
Price Performance
Historical ComparisonAbout CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.